Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement

Ned Calonge, Diana B. Petitti, Thomas G. DeWitt, Leon Gordis, Kimberly D. Gregory, Russell Harris, Kenneth W. Kizer, Michael L. LeFevre, Carol Loveland-Cherry, Lucy N. Marion, Virginia A. Moyer, Judith K. Ockene, George F. Sawaya, Albert L. Siu, Steven M. Teutsch, Barbara P. Yawn

Research output: Contribution to journalReview article

105 Citations (Scopus)

Abstract

This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendation and supporting scientific evidence on routine use of aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer. The complete information on which this statement is based, including evidence tables and references, is available in the accompanying articles in this issue and on the USPSTF Web site (www.preventiveservices.ahrq.gov). The USPSTF is redesigning its recommendation statement in response to feedback from primary care clinicians. The USPSTF plans to release, later in 2007, a new, updated recommendation statement that is easier to read and incorporates advances in USPSTF methodology. The recommendation statement below is an interim version that combines existing language and elements with a new format. Although the definitions of grades remain the same, other elements have been revised.

Original languageEnglish (US)
Pages (from-to)361-364
Number of pages4
JournalAnnals of internal medicine
Volume146
Issue number5
DOIs
StatePublished - Mar 6 2007

Fingerprint

Advisory Committees
Primary Prevention
Aspirin
Colorectal Neoplasms
Anti-Inflammatory Agents
Pharmaceutical Preparations
Primary Health Care
Language

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer : U.S. Preventive Services Task Force recommendation statement. / Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Gordis, Leon; Gregory, Kimberly D.; Harris, Russell; Kizer, Kenneth W.; LeFevre, Michael L.; Loveland-Cherry, Carol; Marion, Lucy N.; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Siu, Albert L.; Teutsch, Steven M.; Yawn, Barbara P.

In: Annals of internal medicine, Vol. 146, No. 5, 06.03.2007, p. 361-364.

Research output: Contribution to journalReview article

Calonge, N, Petitti, DB, DeWitt, TG, Gordis, L, Gregory, KD, Harris, R, Kizer, KW, LeFevre, ML, Loveland-Cherry, C, Marion, LN, Moyer, VA, Ockene, JK, Sawaya, GF, Siu, AL, Teutsch, SM & Yawn, BP 2007, 'Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement', Annals of internal medicine, vol. 146, no. 5, pp. 361-364. https://doi.org/10.7326/0003-4819-146-5-200703060-00008
Calonge, Ned ; Petitti, Diana B. ; DeWitt, Thomas G. ; Gordis, Leon ; Gregory, Kimberly D. ; Harris, Russell ; Kizer, Kenneth W. ; LeFevre, Michael L. ; Loveland-Cherry, Carol ; Marion, Lucy N. ; Moyer, Virginia A. ; Ockene, Judith K. ; Sawaya, George F. ; Siu, Albert L. ; Teutsch, Steven M. ; Yawn, Barbara P. / Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer : U.S. Preventive Services Task Force recommendation statement. In: Annals of internal medicine. 2007 ; Vol. 146, No. 5. pp. 361-364.
@article{3483efdee66f4cf8b730e284841e416e,
title = "Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement",
abstract = "This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendation and supporting scientific evidence on routine use of aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer. The complete information on which this statement is based, including evidence tables and references, is available in the accompanying articles in this issue and on the USPSTF Web site (www.preventiveservices.ahrq.gov). The USPSTF is redesigning its recommendation statement in response to feedback from primary care clinicians. The USPSTF plans to release, later in 2007, a new, updated recommendation statement that is easier to read and incorporates advances in USPSTF methodology. The recommendation statement below is an interim version that combines existing language and elements with a new format. Although the definitions of grades remain the same, other elements have been revised.",
author = "Ned Calonge and Petitti, {Diana B.} and DeWitt, {Thomas G.} and Leon Gordis and Gregory, {Kimberly D.} and Russell Harris and Kizer, {Kenneth W.} and LeFevre, {Michael L.} and Carol Loveland-Cherry and Marion, {Lucy N.} and Moyer, {Virginia A.} and Ockene, {Judith K.} and Sawaya, {George F.} and Siu, {Albert L.} and Teutsch, {Steven M.} and Yawn, {Barbara P.}",
year = "2007",
month = "3",
day = "6",
doi = "10.7326/0003-4819-146-5-200703060-00008",
language = "English (US)",
volume = "146",
pages = "361--364",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "5",

}

TY - JOUR

T1 - Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer

T2 - U.S. Preventive Services Task Force recommendation statement

AU - Calonge, Ned

AU - Petitti, Diana B.

AU - DeWitt, Thomas G.

AU - Gordis, Leon

AU - Gregory, Kimberly D.

AU - Harris, Russell

AU - Kizer, Kenneth W.

AU - LeFevre, Michael L.

AU - Loveland-Cherry, Carol

AU - Marion, Lucy N.

AU - Moyer, Virginia A.

AU - Ockene, Judith K.

AU - Sawaya, George F.

AU - Siu, Albert L.

AU - Teutsch, Steven M.

AU - Yawn, Barbara P.

PY - 2007/3/6

Y1 - 2007/3/6

N2 - This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendation and supporting scientific evidence on routine use of aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer. The complete information on which this statement is based, including evidence tables and references, is available in the accompanying articles in this issue and on the USPSTF Web site (www.preventiveservices.ahrq.gov). The USPSTF is redesigning its recommendation statement in response to feedback from primary care clinicians. The USPSTF plans to release, later in 2007, a new, updated recommendation statement that is easier to read and incorporates advances in USPSTF methodology. The recommendation statement below is an interim version that combines existing language and elements with a new format. Although the definitions of grades remain the same, other elements have been revised.

AB - This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendation and supporting scientific evidence on routine use of aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer. The complete information on which this statement is based, including evidence tables and references, is available in the accompanying articles in this issue and on the USPSTF Web site (www.preventiveservices.ahrq.gov). The USPSTF is redesigning its recommendation statement in response to feedback from primary care clinicians. The USPSTF plans to release, later in 2007, a new, updated recommendation statement that is easier to read and incorporates advances in USPSTF methodology. The recommendation statement below is an interim version that combines existing language and elements with a new format. Although the definitions of grades remain the same, other elements have been revised.

UR - http://www.scopus.com/inward/record.url?scp=33947541519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947541519&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-146-5-200703060-00008

DO - 10.7326/0003-4819-146-5-200703060-00008

M3 - Review article

C2 - 17339621

AN - SCOPUS:33947541519

VL - 146

SP - 361

EP - 364

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 5

ER -